Page last updated: 2024-08-23

fialuridine and Chronic Hepatitis

fialuridine has been researched along with Chronic Hepatitis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Marwick, C	1
De Man, RA; Heijtink, RA; Niesters, HG; Schalm, SW	1

Reviews

1 review(s) available for fialuridine and Chronic Hepatitis

Article	Year
New developments in antiviral therapy for chronic hepatitis B infection. Scandinavian journal of gastroenterology. Supplement, 1995, Volume: 212 Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Famciclovir; Hepatitis B; Hepatitis, Chronic; Humans; Interferon-alpha; Lamivudine; Treatment Outcome; Zalcitabine	1995

Other Studies

1 other study(ies) available for fialuridine and Chronic Hepatitis

Article	Year
NIH panel report of 'no flaws' in FIAU trial at variance with FDA report, new probe planned. JAMA, 1994, Jul-06, Volume: 272, Issue:1 Topics: Antiviral Agents; Arabinofuranosyluracil; Cause of Death; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Hepatitis B; Hepatitis, Chronic; Humans; Liver Diseases; National Institutes of Health (U.S.); Scientific Misconduct; United States; United States Food and Drug Administration	1994

Article

Year

NIH panel report of 'no flaws' in FIAU trial at variance with FDA report, new probe planned.

JAMA, 1994, Jul-06, Volume: 272, Issue:1

Topics: Antiviral Agents; Arabinofuranosyluracil; Cause of Death; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Hepatitis B; Hepatitis, Chronic; Humans; Liver Diseases; National Institutes of Health (U.S.); Scientific Misconduct; United States; United States Food and Drug Administration

1994